Homepage
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Screening Compounds
Building blocks
Drug Discovery Services
Custom Chemistry
Medicinal chemistry
In silico Drug Design (CADD)
Discovery Biology
Animal Models
Toxicology and Safety
ADME, DMPK
Chemistry, Manufacturing and Controls
Company
News & Media
Contact us
For suppliers
Trends in discovery compounds
Homepage
>
Company
>
Media
>
Pharma News
Pharma News
New malaria vaccine effective in clinical trial
University of Tübingen researchers in collaboration with the biotech company Sanaria Inc.
Merck & Co’s HIV drug meets Phase III trial endpoint
US pharma major Merck & Co (NYSE.
U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon's Proposed Biosimilar Pegfilgrastim for Review
HERTFORDSHIRE, England, PITTSBURGH and BENGALURU, India, Feb.
Marathon Pharma to Pause Muscular Dystrophy Drug Launch After Criticism of 6,000% Price Hike
Another drug company reignited the debate over appropriate pricing policies for important medications.
Tom Price confirmed as HHS Secretary
WASHINGTON — Rep.
Merck Announces EPOCH Study of Verubecestat for the Treatment of People with Mild to Moderate Alzheimer’s Disease to Stop for Lack of Efficacy
KENILWORTH, N.
Children may inherit drug protection from fathers' nicotine use
Feb.
Anti-ageing hormone 'Klotho' could prevent kidney disease in diabetics
London.
Immunomedics out-licenses cancer drug candidate for up to $2 billion
The USA’s Immunomedics (Nasdaq.
Drugmaker Ipsen to buy some products from Sanofi for 83 million euros
Drugmaker Ipsen (IPN.
Aspirin, more than painkiller, can help prevent cancer: study
WASHINGTON, Feb.
Aurobindo Pharma to open second U.S. plant
HYDERABAD, India — Aurobindo Pharma said on Friday it plans to open a second U.
555
556
557
558
559
560
561
562
563
